Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Ozempic delivers major weight loss in adults over 65, study finds

Scientists discover why Ozempic works better for some people

Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost

The dark side of weight loss drugs: Ozempic's surprising hidden cost

Weight loss drug Ozempic linked to lower depression and anxiety risk

Scientists discover enzyme that could supercharge Ozempic

Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power

The Next Ozempic? This Unapproved Peptide Comes With a Big Catch

Simple “gut reset” may stop weight gain after Ozempic or Wegovy

Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason

New Study Reveals Why Ozempic Works Better for Some People Than Others

Stopping Weight-Loss Drugs Like Ozempic Can Quickly Erase Heart Benefits

New Drug Could Help Maintain Weight Loss After Ozempic and Wegovy

What happens after Ozempic shocked researchers

Ozempic Is About to Go Generic in India, China and Canada

How drugs like Ozempic are revolutionizing kidney treatment

Wegovy may have highest eye stroke and sight loss risk of semaglutide GLP-1 agonists— Odds of ischaemic optic neuropathy(caused by inadequate/interrupted blood flow to the optic nerve, resulting in sudden vision loss in one or both eyes) nearly 5 times higher than among users of Ozempic

Weight Loss Drugs Like Ozempic and Wegovy Show Surprising Heart Health Benefits

This Week in Science: A Bonus Benefit of Ozempic, Secrets of 'Superagers', And More!

Do Ozempic and Similar Weight Loss Drugs Work for Everyone? New Study Has Answers